Speech-Language Pathologists in Plumerville, AR Accepting Medicare
29 Speech-Language Pathologists found. Showing 21 - 29
 N'speech Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 289 Highway 287, Plumerville, AR 72127 Phone: 501-208-1011 Fax: 501-354-5541 |
 Rhonda R Nosal, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 101 Bulldog Dr, Plumerville, AR 72127 Phone: 501-354-2269 |
Crystal Eary, M.S. CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 101 Bulldog Dr, Plumerville, AR 72127 Phone: 501-354-2269 Fax: 501-354-6947 |
Whitney Doramus, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 101 Bulldog Drive, Plumerville, AR 72127 Phone: 501-354-2269 |
Misty Phillips Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 101 Bulldog Dr, Plumerville, AR 72127 Phone: 501-208-5417 |
Claire Elizabeth Bussey, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 101 Bulldog Dr, Plumerville, AR 72127 Phone: 501-354-2269 |
Haley Copeland, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 101 Bulldog Dr, Plumerville, AR 72127 Phone: 501-208-5404 |
Danielle Schulze, M.S. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 101 Bulldog Dr, Plumerville, AR 72127 Phone: 501-354-2269 |
Mrs. Susan N Welter, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 289 Highway 287, Plumerville, AR 72127 Phone: 501-354-1680 Fax: 501-354-5541 |
News Archive
Research shows role played by PAMPs in immune system signaling and response
How big you are may be as important as what you look like, at least to immune system cells watching for dangerous bacteria and viruses.
Tgen And Baylor secure federal grant to develop early detection system for pancreatic cancer
A group of the nation's premier cancer researchers led by the Baylor Scott & White Research Institute and the Translational Genomics Research Institute - has secured a $5.13 million federal grant to develop an early detection system for pancreatic cancer, the nation's third-leading cause of cancer-related death.
Celator Pharmaceuticals raises $20 million in Series D private equity financing
Celator Pharmaceuticals, a privately held pharmaceutical company developing new and more effective therapies to treat cancer based on the company's proprietary technology, today announced that it raised $20 million in a Series D private equity financing.
Beyond Moose and Mountains initiative focuses on building Canada's business and regulatory environment
At its 2010 annual general meeting in Montreal yesterday, the national biotechnology association, BIOTECanada, confirmed a national team of industry leaders, whose expertise will ensure Canada keeps growing what today is an $84 billion bio-economy.
› Verified 1 days ago
- 1
- 2(current)